At GSK in Canada, we are committed to building transparency related to our operations. We believe it enhances trust and value for patients and our healthcare system. Such transparency improves the relationship between healthcare companies and healthcare professionals – an essential part of patient care, disease understanding and the future of research and discovery of innovative medicines in Canada.
Since 2017, GSK has voluntarily disclosed payments to Healthcare Professionals and Healthcare Organizations. You can view our transparency reporting here, released each June.